Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 2,138 shares at $9.65 ($21K) on 2016-02-19, disclosed to the SEC on 2016-02-22.
Scheduled sale ($21k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.64 | 1,734 | $17K | 81.1% |
| 2 | $9.65 | 404 | $4K | 18.9% |
| Total | $9.64 avg | 2,138 | $21K | 100% |
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |